Please provide your email address to receive an email when new articles are posted on . An experimental gene editing cell therapy for sickle cell disease has shown encouraging early results in a phase ...
Editas Medicine, Inc. EDIT announced that it has entered into a collaboration and nonexclusive license agreement with Canada-based privately held company Genevant Sciences to develop in vivo gene ...
Joint research led by Yutaro Shuto, Ryoya Nakagawa, and Osamu Nureki of the University of Tokyo determined the spatial structure of various processes of a novel gene-editing tool called "prime editor.
Writers have been using AI tools for years – from Microsoft Word’s spellcheck (which often makes unwanted corrections) to the passive-aggressive Grammarly. But ChatGPT is different. ChatGPT’s natural ...